Stockreport

Aktis raises $318M in 2026's first biotech IPO [Yahoo! Finance]

Kyverna Therapeutics, Inc.  (KYTX) 
PDF Radiopharmaceutical drug developer Aktis Oncology on Thursday said it raised $318 million from an initial public offering, the first for a biotechnology company in 2026 [Read more]